Results 211 to 220 of about 31,625 (241)

A Study Of Experimental Relapsing Fever Induced By Borrelia Hermsi.

, 1966
E.M. Coffey
openalex   +1 more source

Periodontitis and Periodontal Conditions in Systemically Healthy Children and Adolescents

Journal of Clinical Periodontology, EarlyView.
ABSTRACT Objective To answer the PICoS question ‘in systemically healthy children and adolescents (Population), what are the main features of periodontitis, necrotising periodontal diseases (NPD) and other periodontal conditions (periodontal abscesses, endo‐periodontal lesions, traumatic occlusal forces, prosthesis‐ and tooth‐related factors ...
Inbar Eshkol‐Yogev, Nagore Ambrosio, Cheryl Somani, Elena Figuero, Lior Shapira, Janet Davies   +5 more
wiley   +1 more source

Some Observations on the Connexion of the New and Full Moon with the Invasion and Relapse of Fevers.

Robert B. Jackson
openalex   +1 more source

The Epidemiology of Relapsing Fever in the Anglo-Egyptian Sudan, including an Experimental Study of the Abyssinian Louse-Borne Strain [PDF]

, 1940
Robert Kirk
openalex  

To the chemotherapy of relapsing fever

, 1923
M. Mastbaum
openalex   +2 more sources

The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD‐ME Group

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Women with inflammatory bowel disease (IBD) and their children are at higher risk of adverse outcomes. The primary aim was to examine the association between IBD and adverse pregnancy outcomes. The secondary aim was to assess the impact of maternal IBD and medications used on children's outcomes.
Mahmoud Mosli, Nahla Azzam, Majid Almadi, Heba Alfarhan, Mansour Altuwaijiri, Abdulrahman Aljebreen, Othman Alharbi, Mohammed Abaalkhail, Maryam Jaran, Abdulaziz Altamimi, Nouf Al Turki, Lubna Alharbi, Joud A. L. Ghamdi, Amal Al Dakhil   +13 more
wiley   +1 more source

Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim Data on sequential immune checkpoint inhibitor (ICI) retreatment following initial atezolizumab plus bevacizumab (Atez + Bev) are limited. This study aimed to evaluate the efficacy and safety of sequential ICI retreatment in patients with unresectable hepatocellular carcinoma (uHCC). Methods Of 835 patients with uHCC treated
Takanori Ito, Shigeo Shimose, Issei Saeki, Yasuto Takeuchi, Joji Tani, Tetsu Tomonari, Ryu Sasaki, Kyo Sasaki, Satoru Kakizaki, Takeshi Hatanaka, Hideki Iwamoto, Norikazu Tanabe, Takafumi Yamamoto, Atsushi Naganuma, Tomotake Shirono, Yuki Kanayama, Hisamitsu Miyaaki, Sohji Nishina, Tetsuji Takayama, Hideki Kobara, Motoyuki Otsuka, Taro Takami, Takumi Kawaguchi, Hiroki Kawashima, Hepatology InVestigator Experts in Japan (HIVE‐J) Study Group   +24 more
wiley   +1 more source

Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology

, 2016
Praveen Sudhindra, Guiqing Wang, Martin E. Schriefer, Donna McKenna, Jian Zhuge, Peter J. Krause, Adriana Marques, Gary P. Wormser   +7 more
openalex   +1 more source

Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management

Journal of Internal Medicine, EarlyView.
Abstract Cryoglobulinemia (CG) is defined by the presence of serum immunoglobulins that precipitate below 37°C and redissolve upon rewarming. It is classified into three types based on immunoglobulin composition. Type I, a rare form, involves monoclonal IgM or IgG and is linked to lymphoproliferative disorders.
Anna Linda Zignego, Laura Gragnani, Marcella Visentini, Riccardo Bomben, Luca Arcaini, Clodoveo Ferri, Valter Gattei, Cesare Mazzaro   +7 more
wiley   +1 more source

The Use of Home Fortification Products in Humanitarian Settings: A Scoping Review

Maternal &Child Nutrition, EarlyView.
ABSTRACT Home fortification products (HFPs), including multiple micronutrient powders and small‐quantity lipid‐based nutrient supplements, are specialized, nutrient‐filled products added to foods with the aim of filling critical nutrient gaps. Despite their potential, there is limited documentation of the use of HFPs in humanitarian settings.
Jacqueline M. Lauer, Alexandra DeShaw, Isabelle Ward, Davidson H. Hamer, Lindsey M. Locks   +4 more
wiley   +1 more source